Literature DB >> 25339675

Creating class I MHC-null pigs using guide RNA and the Cas9 endonuclease.

Luz M Reyes1, Jose L Estrada1, Zheng Yu Wang1, Rachel J Blosser1, Rashod F Smith1, Richard A Sidner1, Leela L Paris1, Ross L Blankenship1, Caitlin N Ray1, Aaron C Miner1, Matthew Tector2, A Joseph Tector3.   

Abstract

Pigs are emerging as important large animal models for biomedical research, and they may represent a source of organs for xenotransplantation. The MHC is pivotal to the function of the immune system in health and disease, and it is particularly important in infection and transplant rejection. Pigs deficient in class I MHC could serve as important reagents to study viral immunity as well as allograft and xenograft rejection. In this study, we report the creation and characterization of class I MHC knockout pigs using the Cas9 nuclease and guide RNAs. Pig fetal fibroblasts were genetically engineered using Cas9 and guide RNAs, and class I MHC(-) cells were then used as nuclear donors for somatic cell nuclear transfer. We produced three piglets devoid of all cell surface class I proteins. Although these animals have reduced levels of CD4(-)CD8(+) T cells in peripheral blood, the pigs appear healthy and are developing normally. These pigs are a promising reagent for immunological research.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25339675      PMCID: PMC5922270          DOI: 10.4049/jimmunol.1402059

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2.

Authors:  R D Salter; R J Benjamin; P K Wesley; S E Buxton; T P Garrett; C Clayberger; A M Krensky; A M Norment; D R Littman; P Parham
Journal:  Nature       Date:  1990-05-03       Impact factor: 49.962

3.  NK susceptibility varies inversely with target cell class I HLA antigen expression.

Authors:  W J Storkus; D N Howell; R D Salter; J R Dawson; P Cresswell
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

4.  Sequence of the pig major histocompatibility region containing the classical class I genes.

Authors:  C Renard; M Vaiman; N Chiannilkulchai; L Cattolico; C Robert; P Chardon
Journal:  Immunogenetics       Date:  2001-08       Impact factor: 2.846

5.  An early pseudorabies virus protein down-regulates porcine MHC class I expression by inhibition of transporter associated with antigen processing (TAP).

Authors:  A P Ambagala; S Hinkley; S Srikumaran
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

6.  Swine generated by somatic cell nuclear transfer have increased incidence of intrauterine growth restriction (IUGR).

Authors:  Jose Estrada; Jeffrey Sommer; Bruce Collins; Bashir Mir; Amy Martin; Abby York; Robert M Petters; Jorge A Piedrahita
Journal:  Cloning Stem Cells       Date:  2007

7.  Characterization of swine leucocyte antigen alleles in a crossbred pig to be used in xenotransplant studies.

Authors:  L M Reyes; R J Blosser; R F Smith; A C Miner; L L Paris; R L Blankenship; M F Tector; A J Tector
Journal:  Tissue Antigens       Date:  2014-09-11

8.  Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man.

Authors:  M Santos; M W Schilham; L H Rademakers; J J Marx; M de Sousa; H Clevers
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

9.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors:  Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal:  Nat Biotechnol       Date:  2013-08-01       Impact factor: 54.908

10.  Synthetic zinc finger proteins: the advent of targeted gene regulation and genome modification technologies.

Authors:  Charles A Gersbach; Thomas Gaj; Carlos F Barbas
Journal:  Acc Chem Res       Date:  2014-05-30       Impact factor: 22.384

View more
  45 in total

1.  Xenotransplantation makes a comeback.

Authors:  Jeffrey M Perkel
Journal:  Nat Biotechnol       Date:  2016-01       Impact factor: 54.908

2.  Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes.

Authors:  Jose L Estrada; Greg Martens; Ping Li; Andrew Adams; Kenneth A Newell; Mandy L Ford; James R Butler; Richard Sidner; Matt Tector; Joseph Tector
Journal:  Xenotransplantation       Date:  2015-03-01       Impact factor: 3.907

Review 3.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

4.  The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.

Authors:  Nienke de Graeff; Karin R Jongsma; Josephine Johnston; Sarah Hartley; Annelien L Bredenoord
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

Review 5.  Exogenous enzymes upgrade transgenesis and genetic engineering of farm animals.

Authors:  Pablo Bosch; Diego O Forcato; Fabrisio E Alustiza; Ana P Alessio; Alejandro E Fili; María F Olmos Nicotra; Ana C Liaudat; Nancy Rodríguez; Thirumala R Talluri; Wilfried A Kues
Journal:  Cell Mol Life Sci       Date:  2015-02-01       Impact factor: 9.261

Review 6.  A review of pig liver xenotransplantation: Current problems and recent progress.

Authors:  Xuan Zhang; Xiao Li; Zhaoxu Yang; Kaishan Tao; Quancheng Wang; Bin Dai; Shibin Qu; Wei Peng; Hong Zhang; David K C Cooper; Kefeng Dou
Journal:  Xenotransplantation       Date:  2019-02-15       Impact factor: 3.907

Review 7.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

8.  Swine Leukocyte Antigen Class II Is a Xenoantigen.

Authors:  Joseph M Ladowski; Luz M Reyes; Gregory R Martens; James R Butler; Zheng-Yu Wang; Devin E Eckhoff; Matthew Tector; A Joseph Tector
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

Review 9.  Xenotransplantation-the current status and prospects.

Authors:  D K C Cooper; R Gaston; D Eckhoff; J Ladowski; T Yamamoto; L Wang; H Iwase; H Hara; M Tector; A J Tector
Journal:  Br Med Bull       Date:  2018-03-01       Impact factor: 4.291

Review 10.  Immunobiological barriers to xenotransplantation.

Authors:  David K C Cooper; Burcin Ekser; A Joseph Tector
Journal:  Int J Surg       Date:  2015-07-06       Impact factor: 6.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.